Woodline Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,335,681
| Closed | -$1.25M | – | 1071 |
|
|
2024
Q4 | $1.25M | Buy |
2,335,681
+1,071,410
| +85% | +$573K | 0.01% | 723 |
|
|
2024
Q3 | $2.23M | Sell |
1,264,271
-2,715,334
| -68% | -$4.78M | 0.02% | 465 |
|
|
2024
Q2 | $4.66M | Buy |
3,979,605
+2,792,824
| +235% | +$3.27M | 0.04% | 345 |
|
|
2024
Q1 | $10.7M | Buy |
1,186,781
+386,781
| +48% | +$3.5M | 0.1% | 252 |
|
|
2023
Q4 | $8.7M | Buy |
800,000
+168,480
| +27% | +$1.83M | 0.09% | 243 |
|
|
2023
Q3 | $5.08M | Sell |
631,520
-168,480
| -21% | -$1.36M | 0.06% | 308 |
|
|
2023
Q2 | $8.69M | Sell |
800,000
-797,411
| -50% | -$8.66M | 0.1% | 219 |
|
|
2023
Q1 | $11M | Buy |
1,597,411
+26,019
| +2% | +$180K | 0.15% | 182 |
|
|
2022
Q4 | $6.25M | Buy |
1,571,392
+203,269
| +15% | +$809K | 0.08% | 282 |
|
|
2022
Q3 | $9.1M | Buy |
+1,368,123
| New | +$9.1M | 0.13% | 212 |
|